India Prostate Cancer Diagnostic and Therapeutic Market Growth, Trends, Competitive Market Share & Forecast - 2025

India prostate cancer market is forecast to grow at a CAGR of around 9% during the forecast period. The incidence of prostate cancer is less as compared to the western economies as prostate cancer is among the top 3 cancer in men in western economies whereas it is at 16th rank in the incidence cancer cases in the country in 2018. As per the World Health Organization, the estimated new cases in 2018 were 26,000- and 5-year prevalence is around 47,500. In India, the registered cases of prostate cancer are more in big cities such as Bangalore, Mumbai, Pune, Kolkata, Delhi, and Thiruvananthapuram. The data for prostate cancer incidences in India is only indicative as there are no PSA testing norms in India at a mass scale which may result in many prostate cancer cases going unreported. In India, data regarding the true incidence of prostate cancer is limited mainly due to the fact that this entity is not a notifiable disease and there are only a handful of population-based cancer registries in India.

Get Sample Copy of India Prostate Cancer Diagnostic and Therapeutic Market at: https://www.omrglobal.com/request-sample/indian-prostate-cancer-diagnostic-therapeutic-market

The companies which are contributing significantly in the market include Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co., Endo Pharmaceuticals Inc., Ferring Pharmaceuticals Inc., GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Siemens Healthcare AG, and others.

Moreover, the country's age composition is that more than 50% of the population is below 25 years of age making it less demanding for prostate cancer services. This is due to the fact that the chances of having prostate cancer in men increase with increasing age. India has a population of 1.3 billion in 2020 and in 2020, the average age of an Indian is around 29 years compared to 37 years for a Chinese and 48 years for a Japanese. This makes it a less demanding market for prostate cancer services and diagnosis.

For More Information, get A full report of India Prostate Cancer Diagnostic and Therapeutic is available at: https://www.omrglobal.com/industry-reports/indian-prostate-cancer-diagnostic-therapeutic-market

However, the market will show impressive growth due to increasing medical tourism in the country. This is primarily due to cheaper healthcare services as compared to western economies. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

India Prostate Cancer Diagnostic and Therapeutic Market Segmentation

India Prostate Cancer Diagnostic and Therapeutic Market by Diagnostic Techniques

o Prostate-Specific Antigen Test (PSA)
o Digital Rectal Examination
o Prostate Biopsy
o Imaging Techniques

India Prostate Cancer Diagnostic and Therapeutic Market by Therapeutics

o Hormonal Therapy
o Chemotherapy
o Immunotherapy
o Radiation Therapy
o Targeted Therapy
o Surgery

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/indian-prostate-cancer-diagnostic-therapeutic-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.